» Articles » PMID: 12034569

Concordant and Discordant Interleukin-1-mediated Signaling in Lung Fibroblast Thy-1 Subpopulations

Overview
Date 2002 May 30
PMID 12034569
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Following lung injury or inflammation, fibroblasts mediate either restorative repair or disordered remodeling. Interleukin (IL)-1beta is a key mediator in the transition from injury/inflammation to tissue remodeling, in part through its regulation of platelet-derived growth factor alpha receptor (PDGFalphaR). Based on prior demonstration of differential PDGFalphaR expression, we hypothesized that subpopulations of fibroblasts would have heterogeneous responses to IL-1. We report that IL-1beta significantly increases expression of PDGFalphaR in Thy-1-, but not Thy-1+ fibroblasts. Higher baseline expression of PDGFalphaR in Thy-1- fibroblasts is partially abrogated by IL-1 receptor antagonist. There are no differences in IL-1beta binding, as determined by flow cytometry, or in the presence of the type I IL-1 receptor (IL-1RtI) or its associated protein (IL-1RacP) by immunoblotting. IL-1beta induces DNA binding of both nuclear factor kappaB (NF-kappaB) and CAATT-enhancer binding protein (C/EBP), and activation of p38 mitogen-activated protein kinase in both subpopulations. However, IL-1beta-induced proliferation and expression of IL-6 are significantly higher in Thy-1- fibroblasts. Heterogeneous responses to IL-1beta despite equivalent presence of both proximal and distal signaling components indicates that parallel signaling pathways are activated selectively in Thy-1- cells, suggesting a prominent role for this subset in the transition from inflammation to lung remodeling.

Citing Articles

Fibroblast Activation Protein Alpha (FAPα) in Fibrosis: Beyond a Perspective Marker for Activated Stromal Cells?.

Basalova N, Alexandrushkina N, Grigorieva O, Kulebyakina M, Efimenko A Biomolecules. 2023; 13(12).

PMID: 38136590 PMC: 10742035. DOI: 10.3390/biom13121718.


Thy-1-Integrin Interactions in and Mediate Distinctive Signaling.

Hu P, Leyton L, Hagood J, Barker T Front Cell Dev Biol. 2022; 10:928510.

PMID: 35733855 PMC: 9208718. DOI: 10.3389/fcell.2022.928510.


A robust vasculogenic microfluidic model using human immortalized endothelial cells and Thy1 positive fibroblasts.

Wan Z, Zhang S, Zhong A, Shelton S, Campisi M, Sundararaman S Biomaterials. 2021; 276:121032.

PMID: 34303155 PMC: 9891349. DOI: 10.1016/j.biomaterials.2021.121032.


Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure.

Li Y, Song D, Mao L, Abraham D, Bursac N Biomaterials. 2020; 236:119824.

PMID: 32028169 PMC: 7024042. DOI: 10.1016/j.biomaterials.2020.119824.


Soluble Thy-1 reverses lung fibrosis via its integrin-binding motif.

Tan C, Jiang M, Wong S, Espinoza C, Kim C, Li X JCI Insight. 2019; 4(21).

PMID: 31672942 PMC: 6948761. DOI: 10.1172/jci.insight.131152.